Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 9 studies | 21% ± 5% | |
lung | 9 studies | 23% ± 8% | |
peripheral blood | 7 studies | 19% ± 5% | |
intestine | 7 studies | 20% ± 6% | |
brain | 6 studies | 26% ± 6% | |
eye | 4 studies | 20% ± 3% | |
liver | 4 studies | 29% ± 11% | |
pancreas | 3 studies | 47% ± 6% | |
bone marrow | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6371.58 | 459 / 459 | 100% | 49.99 | 1118 / 1118 |
esophagus | 100% | 5077.94 | 1445 / 1445 | 100% | 34.07 | 183 / 183 |
intestine | 100% | 5888.07 | 966 / 966 | 100% | 45.08 | 527 / 527 |
liver | 100% | 6408.25 | 226 / 226 | 100% | 32.53 | 406 / 406 |
lung | 100% | 5116.00 | 578 / 578 | 100% | 47.57 | 1155 / 1155 |
ovary | 100% | 4597.12 | 180 / 180 | 100% | 53.04 | 430 / 430 |
pancreas | 100% | 2939.57 | 328 / 328 | 100% | 33.52 | 178 / 178 |
prostate | 100% | 5116.37 | 245 / 245 | 100% | 38.07 | 502 / 502 |
skin | 100% | 6197.48 | 1809 / 1809 | 100% | 64.56 | 472 / 472 |
stomach | 100% | 4413.78 | 359 / 359 | 100% | 39.38 | 286 / 286 |
uterus | 100% | 5116.60 | 170 / 170 | 100% | 55.98 | 459 / 459 |
kidney | 100% | 9434.42 | 89 / 89 | 100% | 42.76 | 900 / 901 |
thymus | 100% | 7365.95 | 653 / 653 | 100% | 46.04 | 604 / 605 |
bladder | 100% | 4909.48 | 21 / 21 | 100% | 45.75 | 503 / 504 |
brain | 100% | 2783.22 | 2630 / 2642 | 100% | 30.54 | 704 / 705 |
adrenal gland | 100% | 5684.95 | 258 / 258 | 95% | 18.81 | 219 / 230 |
adipose | 100% | 6044.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 49.96 | 29 / 29 |
muscle | 100% | 5123.97 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4977.89 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.78 | 1 / 1 |
blood vessel | 100% | 4088.96 | 1333 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 30.44 | 79 / 80 |
heart | 99% | 3986.23 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 6027.84 | 909 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046940 | Biological process | nucleoside monophosphate phosphorylation |
GO_0046033 | Biological process | AMP metabolic process |
GO_0006172 | Biological process | ADP biosynthetic process |
GO_0046034 | Biological process | ATP metabolic process |
GO_0015949 | Biological process | nucleobase-containing small molecule interconversion |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0097226 | Cellular component | sperm mitochondrial sheath |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0004017 | Molecular function | adenylate kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | AK2 |
Protein name | nucleoside-diphosphate kinase (EC 2.7.4.6) Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed] Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) Adenylate kinase 2 |
Synonyms | ADK2 hCG_2032090 |
Description | FUNCTION: Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. Adenylate kinase activity is critical for regulation of the phosphate utilization and the AMP de novo biosynthesis pathways. Plays a key role in hematopoiesis. . FUNCTION: Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. Adenylate kinase activity is critical for regulation of the phosphate utilization and the AMP de novo biosynthesis pathways. Plays a key role in hematopoiesis. . FUNCTION: Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. Adenylate kinase activity is critical for regulation of the phosphate utilization and the AMP de novo biosynthesis pathways. Plays a key role in hematopoiesis. . |
Accessions | ENST00000487289.1 ENST00000480134.5 ENST00000491241.2 F8VY04 P54819 F8VZG5 ENST00000695604.1 ENST00000354858.11 ENST00000695601.1 G3V213 ENST00000695605.1 ENST00000550338.6 ENST00000673291.1 A0A140VK93 ENST00000695602.1 ENST00000467905.5 A0A5F9ZHP2 ENST00000695599.1 A0A8Q3SHW4 ENST00000672715.1 [P54819-1] F8W1A4 ENST00000373449.7 [P54819-2] F8VPP1 ENST00000548033.5 A0A5K1VW67 |